Bausch Health Cos Other Non-Current Liabilities 2010-2024 | BHC

Bausch Health Cos other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Bausch Health Cos Annual Other Non-Current Liabilities
(Millions of US $)
2023 $1,029
2022 $949
2021 $855
2020 $1,228
2019 $1,113
2018 $879
2017 $870
2016 $1,383
2015 $1,264
2014 $506
2013 $571
2012 $621
2011 $488
2010 $226
2009 $73
Bausch Health Cos Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $1,053
2024-06-30 $975
2024-03-31 $976
2023-12-31 $1,029
2023-09-30 $968
2023-06-30 $942
2023-03-31 $965
2022-12-31 $949
2022-09-30 $808
2022-06-30 $712
2022-03-31 $737
2021-12-31 $855
2021-09-30 $1,079
2021-06-30 $1,181
2021-03-31 $1,165
2020-12-31 $1,228
2020-09-30 $1,182
2020-06-30 $1,081
2020-03-31 $25,499
2019-12-31 $1,113
2019-09-30 $1,027
2019-06-30 $1,054
2019-03-31 $1,027
2018-12-31 $879
2018-09-30 $814
2018-06-30 $828
2018-03-31 $880
2017-12-31 $870
2017-09-30 $1,173
2017-06-30 $1,117
2017-03-31 $1,207
2016-12-31 $1,383
2016-09-30 $1,175
2016-06-30 $1,189
2016-03-31 $1,252
2015-12-31 $1,264
2015-09-30 $919
2015-06-30 $824
2015-03-31 $507
2014-12-31 $506
2014-09-30 $534
2014-06-30 $569
2014-03-31 $586
2013-12-31 $571
2013-09-30 $579
2013-06-30 $610
2013-03-31 $666
2012-12-31 $621
2012-09-30 $616
2012-06-30 $652
2012-03-31 $566
2011-12-31 $488
2011-09-30 $534
2011-06-30 $578
2011-03-31 $298
2010-12-31 $226
2010-09-30 $222
2010-06-30 $72
2010-03-31 $72
2009-12-31 $73
2009-09-30 $437
2009-06-30 $509
2009-03-31 $70
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00